These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19593379)

  • 21. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
    Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
    J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis.
    Nieto-Torres JL; DeDiego ML; Verdiá-Báguena C; Jimenez-Guardeño JM; Regla-Nava JA; Fernandez-Delgado R; Castaño-Rodriguez C; Alcaraz A; Torres J; Aguilella VM; Enjuanes L
    PLoS Pathog; 2014 May; 10(5):e1004077. PubMed ID: 24788150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV heptad repeat 2 is a trimer of parallel helices.
    Celigoy J; Ramirez B; Caffrey M
    Protein Sci; 2011 Dec; 20(12):2125-9. PubMed ID: 21922588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
    Toto A; Ma S; Malagrinò F; Visconti L; Pagano L; Stromgaard K; Gianni S
    Protein Sci; 2020 Oct; 29(10):2038-2042. PubMed ID: 32822073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure based computational assessment of channel properties of assembled ORF-8a from SARS-CoV.
    Hsu HJ; Lin MH; Schindler C; Fischer WB
    Proteins; 2015 Feb; 83(2):300-8. PubMed ID: 25394339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Coronavirus E Protein Is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway.
    Westerbeck JW; Machamer CE
    J Virol; 2015 Sep; 89(18):9313-23. PubMed ID: 26136577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion.
    Mahajan M; Chatterjee D; Bhuvaneswari K; Pillay S; Bhattacharjya S
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):407-415. PubMed ID: 28988778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers.
    Mandala VS; McKay MJ; Shcherbakov AA; Dregni AJ; Kolocouris A; Hong M
    Res Sq; 2020 Sep; ():. PubMed ID: 32995764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS coronavirus E protein forms cation-selective ion channels.
    Wilson L; McKinlay C; Gage P; Ewart G
    Virology; 2004 Dec; 330(1):322-31. PubMed ID: 15527857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing interactions of Vpu from HIV-1 with amiloride-based compounds.
    Rosenberg MR; Weaver LM; Casarotto MG
    Biochim Biophys Acta; 2016 Apr; 1858(4):733-9. PubMed ID: 26724207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.
    Madu IG; Roth SL; Belouzard S; Whittaker GR
    J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ORF8a of SARS-CoV forms an ion channel: experiments and molecular dynamics simulations.
    Chen CC; Krüger J; Sramala I; Hsu HJ; Henklein P; Chen YM; Fischer WB
    Biochim Biophys Acta; 2011 Feb; 1808(2):572-9. PubMed ID: 20708597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states.
    McReynolds S; Jiang S; Rong L; Caffrey M
    J Magn Reson; 2009 Dec; 201(2):218-21. PubMed ID: 19819173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin.
    Jaber AA; Chowdhury ZM; Bhattacharjee A; Mourin M; Keya CA; Bhuyan ZA
    Genomics Inform; 2021 Dec; 19(4):e48. PubMed ID: 35172476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus virulence genes with main focus on SARS-CoV envelope gene.
    DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Castaño-Rodriguez C; Fernandez-Delgado R; Usera F; Enjuanes L
    Virus Res; 2014 Dec; 194():124-37. PubMed ID: 25093995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral ion channels: molecular modeling and simulation.
    Sansom MS; Forrest LR; Bull R
    Bioessays; 1998 Dec; 20(12):992-1000. PubMed ID: 10048299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transmembrane oligomers of coronavirus protein E.
    Torres J; Wang J; Parthasarathy K; Liu DX
    Biophys J; 2005 Feb; 88(2):1283-90. PubMed ID: 15713601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu.
    Ewart GD; Mills K; Cox GB; Gage PW
    Eur Biophys J; 2002 Mar; 31(1):26-35. PubMed ID: 12046895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method.
    Takeda M; Chang CK; Ikeya T; Güntert P; Chang YH; Hsu YL; Huang TH; Kainosho M
    J Mol Biol; 2008 Jul; 380(4):608-22. PubMed ID: 18561946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.